GLP-1s, which stands for glucagon-like peptide-1 receptor agonists, are a class of medications developed to manage blood sugar levels in people with Type 2 diabetes
It Can Increase Your Risk of Side Effects When taken as directed, semaglutide can cause side effects like nausea, vomiting, diarrhea, constipation, and stomach pain
Exenatide and rare adverse events
Semaglutide targets one hormone receptor, GLP-1, while tirzepatide targets two, GLP-1 and GIP
Resuming semaglutide after addressing gallbladder issues underscores the importance of a personalized approach to treatment, balancing the benefits of the medication with the individual patients health considerations
Slowed weight loss creates its own stress, which then perpetuates the plateau